Dendrimers As Drugs: Discovery, Preclinical and Clinical Development of SPL7013 Gel (VivaGel™), a Dendrimer Based Microbicide for HIVand STI Prevention
Main Authors: | Matthews Barry, Paull Jeremy, Heery Graham, O'Keefe David, Giannis Michael, Henderson Scott, Karellas Peter, McCarthy Tom, Holan George |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-12-01
|
Series: | Retrovirology |
Similar Items
-
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.
by: Clare F Price, et al.
Published: (2011-01-01) -
A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days.
by: Craig R Cohen, et al.
Published: (2011-01-01) -
Structure activity relationship of dendrimer microbicides with dual action antiviral activity.
by: David Tyssen, et al.
Published: (2010-08-01) -
Dendrimer entrapped microsponge gel of dithranol for effective topical treatment
by: Pushpendra Kumar Tripathi, et al.
Published: (2019-03-01) -
Adsorption of Lead with Silica Gel Modified with Polyamidoamine Dendrimer and Thiomalic Acid
by: Wu Xiongzhi, et al.
Published: (2016-01-01)